Mixed Lymphocyte Culture (3H-TdR Doping Protocol)
GUIDELINE
- Mixed lymphocyte culture (MLC) or mixed lymphocyte reaction (MLR) is a mixture of two unrelated individual lymphocytes cultured together, due to the different histocompatibility antigens on the lymphocyte membranes of the two, they can stimulate each other, resulting in the division of each other's lymphocytes to proliferate and transform. Transformed lymphoblastoid cells show increased cell size, increased synthesis of DNA in the nucleus and RNA in the cytoplasm, etc. The percentage of transformed lymphocytes can be counted morphologically or determined by measuring the amount of 3H-labeled thymidine riboside (3H-TdR) incorporation into activated lymphocytes as a precursor for DNA synthesis. The isotope labeling method is more objective, reproducible, and has more accurate results. The intensity of the proliferative reaction is proportional to the degree of difference between the two histocompatibility antigens. The worse the compatibility between the two, the stronger the reaction.
- This method has two-way and one-way MLC, in two-way MLC, both sides of the lymphocytes stimulate each other to proliferate and transform, that is, both sides of the lymphocytes are both stimulating cells and reactive cells. In one-way MLC, one side of the lymphocytes will be irradiated with X-ray or processed with mitomycin C, so that it loses the ability to proliferate and react but still retains its antigenic stimulating effect, at this time, MLC is only one side of the lymphocytes. In this case, only one side of lymphocytes in the MLC undergoes a proliferative response, so it is possible to understand the intensity of stimulation and proliferative response of lymphocytes in different individuals.
METHODS
- The lymphocyte suspensions of two individuals A and B are labeled separately, with the one of individual A as the response cell of MLC and the one of individual B as the stimulus cell of MLC, and labeled as Bm.
- Take 0.9 mL of lymphocyte suspension from individual B, add 400 μg/mL of mitomycin C 0.1 mL to make the final concentration of 40 μg/mL cell suspension, place in a 37°C water bath for 30 min, centrifuge, and discard the supernatant, the precipitated cells are washed once with culture medium, and the concentration of the cells is adjusted to 1×106/mL.
- Take 0.1 mL of reactive cells (A) and stimulated cells (Bm) in the wells of a round-bottomed cell culture plate (A Bm) with a micro-sampler, meanwhile, set up its control group AA or BBm and a blank control group. The cells are incubated at 37°C in a 5% CO2 incubator for 5 d.
- 15-16 h before the termination of culture, 3H-TdR 1 μL (containing 0.5 μCi) is added to each well using an isotope micro-sampler. Blank control group, no isotope is added at this time.
- Cells are collected on glass fiber filter paper with a cell collector, washed with saline to remove free 3H-TdR, dried in an oven at 60°C, cooled, and then placed into a measuring cup containing scintillation solution, and the intensity of radiation is detected with a α-body scintillometer. The blank control is added with an isotope before sample treatment, and the treatment method is the same as that of the experimental group.
- Expressed as counts per minute (cpm). All samples should be subtracted from the cpm value of the blank control group before data processing. The intensity of the MLC response is usually expressed in terms of the cpm value or stimulation index (SI) of the sample. It can also be expressed in terms of the net cpm value.
NOTES
- The concentration of stimulating cells and responding cells is generally 1:1 or 2:1.
- The culture time is generally 5-6 d, and the 3H-TdR doping time is generally 15-16 h before termination of culture.
- A cell culture plate with a round bottom is preferred.
- Aseptic operation should be observed during the experiment.
- This test can be used for tissue and organ transplantation mating, monitoring indicators of post-transplantation acute rejection and typing of HLA and H-2 class II antigens, and other studies.
- The positive reaction is obvious when the test is done with lymphocytes from two unrelated individuals.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Posters & Downloads
- Protocol
- Tools
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Comparison of the MSCs from Different Sources
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Techniques for Cell Separation
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Cell Cryopreservation Techniques and Practices
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- What Is Cell Proliferation and How to Analyze It?
- Direct vs. Indirect Cell-Based ELISA
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- STR Profiling—The ID Card of Cell Line
- How to Assess the Migratory and Invasive Capacity of Cells?
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- Quantification of Cytokines
- T Cell Activation and Expansion
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Cell Culture Medium
- IL-12 Family Cytokines and Their Immune Functions
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Tips For Cell Cryopreservation
- How to Decide Between 2D and 3D Cell Cultures?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What are the Differences Between M1 and M2 Macrophages?
- Human Primary Cells: Definition, Assay, Applications
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- CHO Cell Line Development
- How to Eliminate Mycoplasma From Cell Cultures?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Isolate PBMCs from Whole Blood?
- How to Handle Mycoplasma in Cell Culture?
- From Shake Flask to Bioreactor: 7 Scale-Up Risks
- How to Interpret ddPCR Results: Common Pitfalls and Troubleshooting
- ddPCR Assay Design for Gene Rearrangement Detection
- Why Your Cells Won't Detach? And How to Fix It?
- How to Identify and Troubleshoot Cell Morphology Changes
- Cell Clumping in Suspension Culture: Causes & Solutions
- Cell Culture Troubleshooting: Molecular Diagnostics & QC for Preclinical R&D
- Cell Density vs. Confluency: How to Optimize Cell Growth
- Cell Immortalization Step by Step
- Cell-Based High-Throughput Screening Techniques
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- Adherent and Suspension Cell Culture
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Role of Cell-Based Assays in Drug Discovery and Development
- Immunogenicity Testing: ELISA and MSD Assays
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Overview of Cell Apoptosis Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- ddPCR vs qPCR vs NGS: Which Platform Fits Your Research?
- Cell Viability, Proliferation and Cytotoxicity Assays
- What Are CAR T Cells?
- Eosinophils vs. Basophils vs. Neutrophils
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Cultivated Meat: What to Know?
- 3D-Cell Model in Cell-Based Assay
- What Are the Pros and Cons of Adoptive Cell Therapy?
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Understanding Immunogenicity Assays: A Comprehensive Guide
-
Histology
- Fluorescent Nuclear Staining Dyes
- Troubleshooting in Fluorescent Staining
- Stains Used in Histology
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- Cell Lysates: Composition, Properties, and Preparation
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Tips for Choosing the Right Protease Inhibitor
- Multiple Animal Tissue Arrays
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Guides for Live Cell Imaging Dyes
- Mitochondrial Staining
- How to Choose the Right Positive and Negative Controls for IHC
- How to Optimize IHC Antibody Dilution: A Practical Guide
- Why Is My IHC Background Too High? A Step-by-Step Troubleshooting Guide
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- What You Must Know About Neuroscience IHC?
- Modern Histological Techniques
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- Multiplexing Immunohistochemistry
- From Specimen to Slide: Core Methods in Histological Practice
- Serum vs. Plasma
- How to Begin with Multiplex Immunohistochemistry (mIHC)
-
Exosome
- Classification, Isolation Techniques and Characterization of Exosomes
- Emerging Technologies and Methodologies for Exosome Research
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- Exosome Transfection for Altering Biomolecular Delivery
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- How to Apply Exosomes in Clinical?
- Techniques for Exosome Quantification
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Perform Targeted Modification of Exosomes?
- How to characterize exosomes?
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Antibodies
- The Role of Exosomes in Cancer
- How to Enhancement Exosome Production?
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- What's the Potential of PELN in Disease Treatment?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- How to Label Exosomes?
- Unraveling Biogenesis and Composition of Exosomes
-
ISH/FISH
- ISH probe labeling method
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- Multiple Approaches to Karyotyping
- Overview of Common FISH Techniques
- In Situ Hybridization Probes
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Guidelines for the Design of FISH Probes
- Small RNA Detection by ISH Methods
- Differences Between DNA and RNA Probes
- Overview of Oligo-FISH Technology
- How to Use FISH in Hematologic Neoplasms?
- FISH Tips and Troubleshooting
- CARD-FISH: Illuminating Microbial Diversity
- What are the Differences between FISH, aCGH, and NGS?
- Comparative Genomic Hybridization and Its Applications
- Telomere Length Measurement Methods
- Different Types of FISH Probes for Oncology Research
- RNAscope ISH Technology
- What Is the Use of FISH in Solid Tumors?
- What Types of Multicolor FISH Probe Sets Are Available?
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- How to Improve ISH Signal-to-Noise Ratio
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Toxicokinetics vs. Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- Traditional vs. Novel Drug Delivery Methods
- Key Factors Influencing Brain Distribution of Drugs
- Overview of In Vitro Permeability Assays
- The Rise of In Vitro Testing in Drug Development
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Key Considerations in Toxicokinetic
- Organ-on-a-Chip Systems for Drug Screening
- How to Design and Synthesize Antibody Drug Conjugates?
- What factors influence drug distribution?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- How to Conduct a Bioavailability Assessment?
- Experimental Methods for Identifying Drug-Drug Interactions
- Physical and Chemical Properties of Drugs and Calculations
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Unraveling the Role of hERG Channels in Drug Safety
- Methods of Parallel Artificial Membrane Permeability Assays
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- What Are Compartment Models in Pharmacokinetics?
- Pharmacokinetics of Therapeutic Peptides
- How to Use iPSC-Derived Hepatocytes in Toxicity Studies
- In Vitro ADME vs In Vivo PK: Why Do Results Diverge?
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- The Bioanalysis Masterclass: Labile Metabolites
- What Are Biomarkers in Drug Discovery?
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- Preclinical Workflow for Drug Toxicity Testing
- 2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?
- Bioanalysis Errors: How to Spot and Fix Them Early
- Troubleshooting Common Issues in Drug Toxicity Testing
- A Complete Guide to CYP Reaction Phenotyping in 2026
- In Vitro ADME vs In Vivo ADME
- Mastering the Noise: A Practical Guide to Minimizing Variability in Preclinical Studies
- Reaction Phenotyping vs. Metabolic Stability
- How to Interpret CYP Phenotyping Data
- When Should You Introduce ADME Tox Testing in Drug Development?
- Biomarkers vs. Functional Assays: Closing the Preclinical Gap
- How Are Biomarkers Validated in Drug Development?
- The Essentials of Quantitative Bioanalysis
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- Why iPSC-derived Cells are Useful in Toxicology?
- Comparing Plasma Protein Binding Methods
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How Can You Optimize Drug Toxicity Assessment?
- Why Cardiotoxicity Matters in R&D?
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- The 8 Types of Drug Toxicity Every Researcher Must Know
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Animal Models of Neurodegenerative Diseases
- Disease Models of Diabetes Mellitus
- Summary of Advantages and Limitations of Different Oncology Animal Models
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
- Scaling Organoid Screening: A Hands-On Guide for 3D Drug Discovery
- Bridging the Translational Gap: A Systematic Framework for Model Selection
- Advanced Organoid Culture: A Practical Optimization Guide
- Are You Choosing the Right Preclinical Model? 10 Key Questions
- How to Match Models to Drug Modalities: Small Molecules vs. Biologics
- How to Select the Right Preclinical Model for Drug Development
- Humanized Mouse Models: Core Technical Considerations
- Animal Models vs. NAMs: Understanding Modern Preclinical Research
- How to Select the Right Humanized Mouse Model for Immuno-Oncology
- Organoids vs Organ-on-Chip: Which is More Predictive?
- Implementing NAMs in Drug Development
- Organ-on-a-Chip: Is Your Microfluidic Setup Ready for Preclinical Trials?
- Why Oncology Organoids Fail? How to Build Models That Work
- Oncology Model Strategy: From Screening to Validation
- Static vs. Dynamic In Vitro Models
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter
